639 related articles for article (PubMed ID: 22875086)
41. ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations.
Chiò A; Restagno G; Brunetti M; Ossola I; Calvo A; Canosa A; Moglia C; Floris G; Tacconi P; Marrosu F; Marrosu MG; Murru MR; Majounie E; Renton AE; Abramzon Y; Pugliatti M; Sotgiu MA; Traynor BJ; Borghero G;
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):730-3. PubMed ID: 22550220
[TBL] [Abstract][Full Text] [Related]
42. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
[TBL] [Abstract][Full Text] [Related]
43. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
44. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
[TBL] [Abstract][Full Text] [Related]
45. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia.
Fratta P; Poulter M; Lashley T; Rohrer JD; Polke JM; Beck J; Ryan N; Hensman D; Mizielinska S; Waite AJ; Lai MC; Gendron TF; Petrucelli L; Fisher EM; Revesz T; Warren JD; Collinge J; Isaacs AM; Mead S
Acta Neuropathol; 2013 Sep; 126(3):401-9. PubMed ID: 23818065
[TBL] [Abstract][Full Text] [Related]
46. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
Rutherford NJ; Heckman MG; Dejesus-Hernandez M; Baker MC; Soto-Ortolaza AI; Rayaprolu S; Stewart H; Finger E; Volkening K; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Knopman DS; Kretzschmar HA; Neumann M; Caselli RJ; White CL; Mackenzie IR; Petersen RC; Strong MJ; Miller BL; Boeve BF; Uitti RJ; Boylan KB; Wszolek ZK; Graff-Radford NR; Dickson DW; Ross OA; Rademakers R
Neurobiol Aging; 2012 Dec; 33(12):2950.e5-7. PubMed ID: 22840558
[TBL] [Abstract][Full Text] [Related]
47. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
[TBL] [Abstract][Full Text] [Related]
48. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.
Smith BN; Newhouse S; Shatunov A; Vance C; Topp S; Johnson L; Miller J; Lee Y; Troakes C; Scott KM; Jones A; Gray I; Wright J; Hortobágyi T; Al-Sarraj S; Rogelj B; Powell J; Lupton M; Lovestone S; Sapp PC; Weber M; Nestor PJ; Schelhaas HJ; Asbroek AA; Silani V; Gellera C; Taroni F; Ticozzi N; Van den Berg L; Veldink J; Van Damme P; Robberecht W; Shaw PJ; Kirby J; Pall H; Morrison KE; Morris A; de Belleroche J; Vianney de Jong JM; Baas F; Andersen PM; Landers J; Brown RH; Weale ME; Al-Chalabi A; Shaw CE
Eur J Hum Genet; 2013 Jan; 21(1):102-8. PubMed ID: 22692064
[TBL] [Abstract][Full Text] [Related]
49. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
50. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes.
Fratta P; Mizielinska S; Nicoll AJ; Zloh M; Fisher EM; Parkinson G; Isaacs AM
Sci Rep; 2012; 2():1016. PubMed ID: 23264878
[TBL] [Abstract][Full Text] [Related]
51. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
52. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
53. C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.
König T; Wurm R; Parvizi T; Silvaieh S; Hotzy C; Cetin H; Klotz S; Gelpi E; Bancher C; Benke T; Dal-Bianco P; Defrancesco M; Fischer P; Marksteiner J; Sutterlüty H; Ransmayr G; Schmidt R; Zimprich A; Stögmann E
Neurobiol Dis; 2022 Dec; 175():105927. PubMed ID: 36379394
[TBL] [Abstract][Full Text] [Related]
54. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
55. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
[TBL] [Abstract][Full Text] [Related]
56. FTD/ALS families are no longer orphaned: the C9ORF72 story.
van Swieten JC; Grossman M
Neurology; 2012 Sep; 79(10):962-4. PubMed ID: 22875094
[No Abstract] [Full Text] [Related]
57. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan.
Tsai CP; Soong BW; Tu PH; Lin KP; Fuh JL; Tsai PC; Lu YC; Lee IH; Lee YC
Neurobiol Aging; 2012 Sep; 33(9):2232.e11-2232.e18. PubMed ID: 22673113
[TBL] [Abstract][Full Text] [Related]
58. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile.
Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR
JAMA Neurol; 2014 Mar; 71(3):331-9. PubMed ID: 24445580
[TBL] [Abstract][Full Text] [Related]
59. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
Todd TW; Petrucelli L
J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
[TBL] [Abstract][Full Text] [Related]
60. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.
Lindquist SG; Duno M; Batbayli M; Puschmann A; Braendgaard H; Mardosiene S; Svenstrup K; Pinborg LH; Vestergaard K; Hjermind LE; Stokholm J; Andersen BB; Johannsen P; Nielsen JE
Clin Genet; 2013 Mar; 83(3):279-83. PubMed ID: 22650353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
